Status:
COMPLETED
Image-Guided Stereotactic Biopsy of High Grade Gliomas
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Brain Cancer
Glioma
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate high and low areas of growth, or proliferation, within the tumor. An imaging technique using a very small amount of a radioactive tracer called 18Ffluoro-deoxy...
Eligibility Criteria
Inclusion
- Age \> or = to 18 years old.
- Radiographic appearance of a lesion presumed to be high-grade glioma.
- Planned surgical resection.
Exclusion
- All patients who have been previously treated with radiation, chemotherapy, or other targeted drugs (patients only) for their brain tumor.
- Pregnant (confirmed by serum b-HCG in women of reproductive age) or breast feeding.
- Patients with other active malignancies or prior treatment for non-CNS malignancies.
Key Trial Info
Start Date :
September 16 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00979810
Start Date
September 16 2009
End Date
February 24 2020
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065